Krystal Biotech (KRYS) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Krystal Biotech · Health Care · ref. ETF XLV · 84 calls · price $321.16
What the company does: Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
📈 Krystal Biotech (KRYS) stock price
$321.16+70.8% over range
Oct 14, 25low $185.05 · high $378.15Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 6 analysts
📊 JPI status : Krystal Biotech has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 KRYS price target & analyst consensus — price $321
The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$403+25.5%
Median target · of 6 targets$393+22.4%
Lowest target · 1 firm of 6$300-6.6%
Current price$321.16
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
583%
$361 ↔ $403
Below
117%
$300
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: B of A Securities — 74% of its targets hit on this sector (109 calls tested). It aims for $400 (+25 %), call made on September 22, 2026, maturing on September 22, 2027 (22 d ago).
The 3 reliable analysts
$400+25 %
The 3 other firms
$361+12 %
How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $400 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy6100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 KRYS price target all
All 84 calls, one by one, with our verdict on each firm.
→ See all 84 targets, analyst by analyst💡 The best analysts on KRYS most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in KRYS? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Krystal Biotech? The JPI assistant answers using our backtest data.
📈 Krystal Biotech fundamentals: valuation, margins & growth › open the full page
P/E 40.2Net margin 54.8 %Revenue growth +24.1 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
2023
marg. 22 %
2024
Rev +473%Profit +716%
2025
Rev +34%Profit +130%
🔎 Detailed analyses
🏛️ Which US Congress members hold Krystal Biotech (KRYS)?
1 Congress member has disclosed KRYS buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Christopher Jacobs 1× · 21%
✅ Historical analyst reliability on KRYS
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| B of A Securities ↗ | 100% | +56.5% | 4 |
| Guggenheim ↗ | 100% | +55.3% | 6 |
| Citigroup ↗ | 100% | +33.8% | 2 |
| Chardan Capital | 93% | +73.3% | 15 |
| Goldman Sachs ↗ | 90% | +52.9% | 10 |
| Cantor Fitzgerald ↗ | 83% | +53.3% | 6 |
| HC Wainwright & Co. ↗ | 71% | +43.3% | 34 |
| Stifel ↗ | 50% | +24.5% | 4 |
📊 What $1,000 invested in Krystal Biotech would be worth › open the full page
In short — $1,000 invested in Krystal Biotech 10 years ago would be worth $33,741 today, i.e. +48%/yr on average. Best year: 2018 (+141%), worst: 2020 (+1%). Price performance, excluding dividends.
If I'd invested $1,000 in Krystal Biotech
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $2,144 | +114% |
| 3 years ago | $4,285 | +328% |
| 5 years ago | $5,657 | +466% |
Return by year (Krystal Biotech)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +37% | $1,375 (+37%) |
| 2025 | +56% | $2,144 (+114%) |
| 2024 | +28% | $2,736 (+174%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Krystal Biotech
Loading news…
📋 All analyst calls on KRYS
Filtered on — · ✕ show all
B of A Securities ↗
Sep 21, 26
▲ Buy · 🎯$400
Price at call : $350.88 — upside +14%
Today : $321.16 — upside +25%
🎯 on KRYS : 100% (1 call matured) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Sep 21, 27
matures : Sep 21, 27
RBC Capital ↗
Aug 14, 26
▲ Outperform · 🎯$400
Price at call : $335.73 — upside +19%
Today : $321.16 — upside +25%
🎯 on KRYS : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Aug 14, 27
matures : Aug 14, 27
▲ Buy · 🎯$386
Price at call : $325.78 — upside +18%
Today : $321.16 — upside +20%
🎯 on KRYS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
B of A Securities ↗
Jul 14, 26
▲ Buy · 🎯$396
Price at call : $350.24 — upside +13%
Today : $321.16 — upside +23%
🎯 on KRYS : 100% (1 call matured) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
▲ Buy · 🎯$403
Price at call : $343.43 — upside +17%
Today : $321.16 — upside +25%
🎯 on KRYS : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Jun 18, 27
matures : Jun 18, 27
HC Wainwright & Co. ↗
Jun 16, 26
▲ Buy · 🎯$361
Price at call : $341.66 — upside +6%
Today : $321.16 — upside +12%
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Jun 16, 27
matures : Jun 16, 27
HC Wainwright & Co. ↗
Jun 1, 26
▲ Buy · 🎯$310
Price at call : $298.1 — upside +4%
Today : $321.16 — upside -3%
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Jun 1, 27
matures : Jun 1, 27
HC Wainwright & Co. ↗
May 22, 26
▲ Buy · 🎯$310
Price at call : $299.45 — upside +4%
Today : $321.16 — upside -3%
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
See the other 76 calls, newest to oldest
HC Wainwright & Co. ↗
May 18, 26
▲ Buy · 🎯$310
Price at call : $291.75 — upside +6%
Today : $321.16 — upside -3%
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
▲ Buy · 🎯$378
Price at call : $288.99 — upside +31%
Today : $321.16 — upside +18%
🎯 on KRYS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Evercore ISI Group ↗
May 5, 26
▲ Outperform · 🎯$300
Price at call : $288.99 — upside +4%
Today : $321.16 — upside -7%
🎯 on KRYS : no call matured yet · 📊 on Health : 39.1% · -4.9% (46 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
HC Wainwright & Co. ↗
May 4, 26
▲ Buy · 🎯$310
Price at call : $284.57 — upside +9%
Today : $321.16 — upside -3%
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
Wolfe Research ↗
Mar 27, 26
■ Peer Perform neutral · not a buy
🎯 on KRYS : no call matured yet · 📊 on Health : 46.2% · +2.9% (13 calls)
in progress (365j)
matures : Mar 27, 27
matures : Mar 27, 27
Guggenheim ↗
Feb 25, 26
▲ Buy · 🎯$284
Price at call : $272.5 — upside +4%
Today : $321.16 — upside -12%
🎯 on KRYS : 100% (6 calls matureds) · 📊 on Health : 69.8% · +22.2% (53 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Buy · 🎯$371
Price at call : $262.67 — upside +41%
Today : $321.16 — upside +16%
🎯 on KRYS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
Chardan Capital
Feb 18, 26
▲ Buy · 🎯$323
Price at call : $283.29 — upside +14%
Today : $321.16 — upside +1%
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
in progress (365j)
matures : Feb 18, 27
matures : Feb 18, 27
▲ Buy · 🎯$371
Price at call : $283.29 — upside +31%
Today : $321.16 — upside +16%
🎯 on KRYS : 100% (1 call matured) · 📊 on Health : 48.3% · +10.7% (116 calls)
in progress (365j)
matures : Feb 17, 27
matures : Feb 17, 27
Goldman Sachs ↗
Feb 2, 26
▲ Buy · 🎯$327
Price at call : $279.57 — upside +17%
Today : $321.16 — upside +2%
🎯 on KRYS : 90% (10 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
B of A Securities ↗
Jan 22, 26
▲ Buy · 🎯$318
Price at call : $281.53 — upside +13%
Today : $321.16 — upside -1%
🎯 on KRYS : 100% (1 call matured) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Jan 22, 27
matures : Jan 22, 27
▲ Buy · 🎯$336
Price at call : $291.93 — upside +15%
Today : $321.16 — upside +5%
🎯 on KRYS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Jan 12, 27
matures : Jan 12, 27
▲ Buy · 🎯$306
Price at call : $272.13 — upside +12%
Today : $321.16 — upside -5%
🎯 on KRYS : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Buy · 🎯$320
Price at call : $272.13 — upside +18%
Today : $321.16 — upside -0%
🎯 on KRYS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
HC Wainwright & Co. ↗
Jan 9, 26
▲ Buy · 🎯$310
Price at call : $261.41 — upside +19%
Today : $321.16 — upside -3%
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Buy · 🎯$309
Price at call : $249.39 — upside +24%
Today : $321.16 — upside -4%
🎯 on KRYS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Jan 6, 27
matures : Jan 6, 27
■ Neutral neutral · not a buy · 🎯$198
Price at call : $199.88 — gap to target -1%
Today : $321.16 — gap to target -38%
🎯 on KRYS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
Chardan Capital
Nov 4, 25
▲ Buy · 🎯$220
Price at call : $203.26 — upside +8%
Today : $321.16 — upside -31%
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
B of A Securities ↗
Oct 17, 25
▲ Buy · 🎯$255
Price at call : $190.23 — upside +34%
Today : $321.16 — upside -21%
🎯 on KRYS : 100% (1 call matured) · 📊 on Health : 64.2% · +20.2% (109 calls)
in progress (365j)
matures : Oct 17, 26
matures : Oct 17, 26
HC Wainwright & Co. ↗
Sep 15, 25
▲ Buy · 🎯$240
Price at call : $154.38 — upside +55%
Today : $321.16 — upside -25%
Expected +55% · Actual +118% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+118.1%
stock +118% · XLV +23%
matured Sep 15, 26
Chardan Capital
Aug 22, 25
▲ Buy · 🎯$216
Price at call : $150.49 — upside +44%
Today : $321.16 — upside -33%
Expected +44% · Actual +127% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+127.1%
stock +127% · XLV +26%
matured Aug 22, 26
HC Wainwright & Co. ↗
Aug 22, 25
▲ Buy · 🎯$240
Price at call : $150.49 — upside +59%
Today : $321.16 — upside -25%
Expected +59% · Actual +127% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+127.1%
stock +127% · XLV +26%
matured Aug 22, 26
■ Neutral neutral · not a buy · 🎯$166
Price at call : $136 — gap to target +22%
Today : $321.16 — gap to target -48%
🎯 on KRYS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Aug 5, 26
matures : Aug 5, 26
Chardan Capital
Aug 5, 25
▲ Buy · 🎯$219
Price at call : $137.35 — upside +59%
Today : $321.16 — upside -32%
Expected +59% · Actual +137% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+137.2%
stock +137% · XLV +24%
matured Aug 5, 26
Chardan Capital
Jul 25, 25
▲ Buy · 🎯$219
Price at call : $147.61 — upside +48%
Today : $321.16 — upside -32%
Expected +48% · Actual +138% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+138.3%
stock +138% · XLV +20%
matured Jul 25, 26
HC Wainwright & Co. ↗
Jul 25, 25
▲ Buy · 🎯$240
Price at call : $147.61 — upside +63%
Today : $321.16 — upside -25%
Expected +63% · Actual +138% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+138.3%
stock +138% · XLV +20%
matured Jul 25, 26
B of A Securities ↗
Jul 22, 25
▲ Buy · 🎯$192
Price at call : $153.25 — upside +25%
Today : $321.16 — upside -40%
Expected +25% · Actual +114% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (1 call matured) · 📊 on Health : 64.2% · +20.2% (109 calls)
+113.7%
stock +114% · XLV +18%
matured Jul 22, 26
■ Neutral neutral · not a buy · 🎯$176
Price at call : $148.17 — gap to target +19%
Today : $321.16 — gap to target -45%
🎯 on KRYS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Jul 10, 26
matures : Jul 10, 26
Clear Street
Jul 1, 25
▲ Buy · 🎯$190
Price at call : $141.35 — upside +34%
Today : $321.16 — upside -41%
Expected +34% · Actual +165% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (1 call matured) · 📊 unranked overall
+165.3%
stock +165% · XLV +21%
matured Jul 1, 26
HC Wainwright & Co. ↗
Jun 24, 25
▲ Buy · 🎯$240
Price at call : $142.5 — upside +68%
Today : $321.16 — upside -25%
Expected +68% · Actual +153% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+152.6%
stock +153% · XLV +16%
matured Jun 24, 26
■ Neutral neutral · not a buy · 🎯$155
Price at call : $132.29 — gap to target +17%
Today : $321.16 — gap to target -52%
🎯 on KRYS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : May 16, 26
matures : May 16, 26
Guggenheim ↗
May 7, 25
▲ Buy · 🎯$189
Price at call : $137.17 — upside +38%
Today : $321.16 — upside -41%
Expected +38% · Actual +123% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (6 calls matureds) · 📊 on Health : 69.8% · +22.2% (53 calls)
+122.9%
stock +123% · XLV +7%
matured May 7, 26
Chardan Capital
May 7, 25
▲ Buy · 🎯$219
Price at call : $136.8 — upside +60%
Today : $321.16 — upside -32%
Expected +60% · Actual +117% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+116.9%
stock +117% · XLV +7%
matured May 7, 26
HC Wainwright & Co. ↗
May 6, 25
▲ Buy · 🎯$240
Price at call : $136.8 — upside +75%
Today : $321.16 — upside -25%
Expected +75% · Actual +117% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+116.9%
stock +117% · XLV +7%
matured May 6, 26
HC Wainwright & Co. ↗
Apr 29, 25
▲ Buy · 🎯$240
Price at call : $169.88 — upside +41%
Today : $321.16 — upside -25%
Expected +41% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+54.4%
stock +54% · XLV +4%
matured Apr 29, 26
HC Wainwright & Co. ↗
Apr 28, 25
▲ Buy · 🎯$240
Price at call : $170.57 — upside +41%
Today : $321.16 — upside -25%
Expected +41% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+52.4%
stock +52% · XLV +3%
matured Apr 28, 26
▲ Buy · 🎯$245
Price at call : $180.06 — upside +36%
Today : $321.16 — upside -24%
Expected +36% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (1 call matured) · 📊 on Health : 48.3% · +10.7% (116 calls)
+44.6%
stock +45% · XLV +3%
matured Mar 5, 26
HC Wainwright & Co. ↗
Feb 28, 25
▲ Buy · 🎯$221
Price at call : $179.25 — upside +23%
Today : $321.16 — upside -31%
Expected +23% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+44.4%
stock +44% · XLV +6%
matured Feb 28, 26
■ Neutral neutral · not a buy · 🎯$215
Price at call : $187.86 — gap to target +14%
Today : $321.16 — gap to target -33%
🎯 on KRYS : no call matured yet · 📊 on Health : 57% · +17.6% (128 calls)
in progress (365j)
matures : Feb 20, 26
matures : Feb 20, 26
Cantor Fitzgerald ↗
Feb 20, 25
▲ Overweight · 🎯$215
Price at call : $187.86 — upside +14%
Today : $321.16 — upside -33%
Expected +14% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+46.2%
stock +46% · XLV +8%
matured Feb 20, 26
Chardan Capital
Feb 20, 25
▲ Buy · 🎯$218
Price at call : $182.62 — upside +19%
Today : $321.16 — upside -32%
Expected +19% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+43.4%
stock +43% · XLV +7%
matured Feb 20, 26
HC Wainwright & Co. ↗
Feb 19, 25
▲ Buy · 🎯$221
Price at call : $182.62 — upside +21%
Today : $321.16 — upside -31%
Expected +21% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+43.4%
stock +43% · XLV +7%
matured Feb 19, 26
Chardan Capital
Dec 18, 24
▲ Buy · 🎯$212
Price at call : $160.83 — upside +32%
Today : $321.16 — upside -34%
Expected +32% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+49.7%
stock +50% · XLV +14%
matured Dec 18, 25
HC Wainwright & Co. ↗
Dec 18, 24
▲ Buy · 🎯$221
Price at call : $156.64 — upside +41%
Today : $321.16 — upside -31%
Expected +41% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+49.0%
stock +49% · XLV +12%
matured Dec 18, 25
HC Wainwright & Co. ↗
Dec 13, 24
▲ Buy · 🎯$221
Price at call : $163.64 — upside +35%
Today : $321.16 — upside -31%
Expected +35% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+48.5%
stock +48% · XLV +11%
matured Dec 13, 25
Chardan Capital
Dec 12, 24
▲ Buy · 🎯$212
Price at call : $163.64 — upside +30%
Today : $321.16 — upside -34%
Expected +30% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+48.5%
stock +48% · XLV +11%
matured Dec 12, 25
HC Wainwright & Co. ↗
Dec 10, 24
▲ Buy · 🎯$221
Price at call : $185.74 — upside +19%
Today : $321.16 — upside -31%
Expected +19% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (12 calls matureds) · 📊 on Health : 69% · +25.4% (248 calls)
+29.1%
stock +29% · XLV +6%
matured Dec 10, 25
Cantor Fitzgerald ↗
Aug 29, 24
▲ Overweight
Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on KRYS : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-23.6%
stock -24% · XLV -12%
matured Aug 29, 25
Chardan Capital
Aug 6, 24
▲ Buy · 🎯$208
Price at call : $178.61 — upside +16%
Today : $321.16 — upside -35%
Expected +16% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
-23.9%
stock -24% · XLV -12%
matured Aug 6, 25
Guggenheim ↗
Feb 27, 24
▲ Buy · 🎯$175
Price at call : $163.08 — upside +7%
Today : $321.16 — upside -46%
Expected +7% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on KRYS : 100% (6 calls matureds) · 📊 on Health : 69.8% · +22.2% (53 calls)
+6.3%
stock +6% · XLV +1%
matured Feb 26, 25
Cantor Fitzgerald ↗
Dec 13, 23
▲ Overweight · 🎯$180
Price at call : $116.28 — upside +55%
Today : $321.16 — upside -44%
Expected +55% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+40.7%
stock +41% · XLV +4%
matured Dec 12, 24
Goldman Sachs ↗
Nov 20, 23
▲ Buy · 🎯$160
Price at call : $104.78 — upside +53%
Today : $321.16 — upside -50%
Expected +53% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 90% (10 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
+69.7%
stock +70% · XLV +9%
matured Nov 19, 24
Cantor Fitzgerald ↗
Nov 7, 23
▲ Overweight · 🎯$160
Price at call : $102.25 — upside +56%
Today : $321.16 — upside -50%
Expected +56% · Actual +81% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+81.4%
stock +81% · XLV +16%
matured Nov 6, 24
Cantor Fitzgerald ↗
Oct 24, 23
▲ Overweight · 🎯$160
Price at call : $117.05 — upside +37%
Today : $321.16 — upside -50%
Expected +37% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+47.6%
stock +48% · XLV +18%
matured Oct 23, 24
Chardan Capital
Aug 8, 23
▲ Buy · 🎯$153
Price at call : $115.89 — upside +32%
Today : $321.16 — upside -52%
Expected +32% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+50.7%
stock +51% · XLV +8%
matured Aug 7, 24
Guggenheim ↗
May 22, 23
▲ Buy · 🎯$130
Price at call : $117.53 — upside +11%
Today : $321.16 — upside -60%
Expected +11% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (6 calls matureds) · 📊 on Health : 69.8% · +22.2% (53 calls)
+41.9%
stock +42% · XLV +11%
matured May 21, 24
Goldman Sachs ↗
May 22, 23
▲ Buy · 🎯$155
Price at call : $117.53 — upside +32%
Today : $321.16 — upside -52%
Expected +32% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 90% (10 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
+41.9%
stock +42% · XLV +11%
matured May 21, 24
Chardan Capital
May 22, 23
▲ Buy · 🎯$148
Price at call : $117.53 — upside +26%
Today : $321.16 — upside -54%
Expected +26% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+41.9%
stock +42% · XLV +11%
matured May 21, 24
Goldman Sachs ↗
May 7, 23
▲ Buy · 🎯$135
Price at call : $87.65 — upside +54%
Today : $321.16 — upside -58%
Expected +54% · Actual +85% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 90% (10 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
+84.5%
stock +85% · XLV +7%
matured May 6, 24
Guggenheim ↗
Feb 28, 23
▲ Buy · 🎯$101
Price at call : $83 — upside +22%
Today : $321.16 — upside -69%
Expected +22% · Actual +92% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (6 calls matureds) · 📊 on Health : 69.8% · +22.2% (53 calls)
+92.1%
stock +92% · XLV +14%
matured Feb 28, 24
Goldman Sachs ↗
Feb 28, 23
▲ Buy · 🎯$124
Price at call : $81.91 — upside +51%
Today : $321.16 — upside -61%
Expected +51% · Actual +99% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 90% (10 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
+99.1%
stock +99% · XLV +15%
matured Feb 28, 24
Chardan Capital
Feb 28, 23
▲ Buy · 🎯$133
Price at call : $81.91 — upside +62%
Today : $321.16 — upside -59%
Expected +62% · Actual +99% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+99.1%
stock +99% · XLV +15%
matured Feb 28, 24
Chardan Capital
Nov 8, 22
▲ Buy · 🎯$133
Price at call : $78.88 — upside +69%
Today : $321.16 — upside -59%
Expected +69% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+29.6%
stock +30% · XLV -4%
matured Nov 8, 23
Chardan Capital
Aug 9, 22
▲ Buy · 🎯$130
Price at call : $77.8 — upside +67%
Today : $321.16 — upside -60%
Expected +67% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+52.3%
stock +52% · XLV +3%
matured Aug 9, 23
Goldman Sachs ↗
Aug 8, 22
▲ Buy · 🎯$74
Price at call : $77.8 — upside -5%
Today : $321.16 — upside -77%
Expected -5% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 90% (10 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
+52.3%
stock +52% · XLV +3%
matured Aug 8, 23
Goldman Sachs ↗
May 24, 22
▲ Buy · 🎯$78
Price at call : $55.32 — upside +41%
Today : $321.16 — upside -76%
Expected +41% · Actual +112% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 90% (10 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
+112.2%
stock +112% · XLV -3%
matured May 24, 23
Goldman Sachs ↗
Mar 1, 22
▲ Buy · 🎯$93
Price at call : $65.37 — upside +42%
Today : $321.16 — upside -71%
Expected +42% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 90% (10 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
+25.2%
stock +25% · XLV -3%
matured Mar 1, 23
Goldman Sachs ↗
Nov 29, 21
▲ Buy · 🎯$125
Price at call : $80.55 — upside +55%
Today : $321.16 — upside -61%
Expected +55% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on KRYS : 90% (10 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
-3.5%
stock -3% · XLV +7%
matured Nov 29, 22
Goldman Sachs ↗
Aug 9, 21
▲ Buy · 🎯$87
Price at call : $58.94 — upside +48%
Today : $321.16 — upside -73%
Expected +48% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 90% (10 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
+29.8%
stock +30% · XLV -0%
matured Aug 9, 22
Goldman Sachs ↗
Jul 20, 21
▲ Buy · 🎯$90
Price at call : $62.89 — upside +43%
Today : $321.16 — upside -72%
Expected +43% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 90% (10 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
+17.2%
stock +17% · XLV -0%
matured Jul 20, 22
Chardan Capital
Aug 19, 20
▲ Buy · 🎯$115
Price at call : $47.73 — upside +141%
Today : $321.16 — upside -64%
Expected +141% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+9.0%
stock +9% · XLV +26%
matured Aug 19, 21
Guggenheim ↗
Jun 25, 19
▲ Buy · 🎯$73
Price at call : $39.4 — upside +85%
Today : $321.16 — upside -77%
Expected +85% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on KRYS : 100% (6 calls matureds) · 📊 on Health : 69.8% · +22.2% (53 calls)
+8.0%
stock +8% · XLV +8%
matured Jun 24, 20
Guggenheim ↗
May 30, 19
▲ Buy
Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (6 calls matureds) · 📊 on Health : 69.8% · +22.2% (53 calls)
+60.7%
stock +61% · XLV +17%
matured May 29, 20
Cantor Fitzgerald ↗
Sep 11, 18
▲ Overweight · 🎯$28
Price at call : $21 — upside +33%
Today : $321.16 — upside -91%
Expected +33% · Actual +127% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 83% (6 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+127.5%
stock +127% · XLV -1%
matured Sep 11, 19
Chardan Capital
Jun 28, 18
▲ Buy · 🎯$35
Price at call : $14.42 — upside +143%
Today : $321.16 — upside -89%
Expected +143% · Actual +179% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 93% (15 calls matureds) · 📊 on Health : 60.5% · +52.5% (38 calls)
+179.3%
stock +179% · XLV +11%
matured Jun 28, 19
Ladenburg Thalmann ↗
Oct 18, 17
▲ Buy · 🎯$23
Price at call : $11.19 — upside +106%
Today : $321.16 — upside -93%
Expected +106% · Actual +85% · Reason (≥ +15%) : ✓ Yes
🎯 on KRYS : 100% (1 call matured) · 📊 on Health : 77.8% · +22.6% (9 calls)
+84.6%
stock +85% · XLV +11%
matured Oct 18, 18
Frequently asked questions
Should I buy Krystal Biotech stock?
This isn't buy advice. For Krystal Biotech, the analyst consensus is "Buy", with an average price target of $393 (+22% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Krystal Biotech). We show the numbers — you decide.
Is it too late to buy Krystal Biotech? How high can it go?
The most bullish analyst target on Krystal Biotech is $403 (+25% above today's price); the average is $393. That's the upside they see. Check how reliable those analysts have actually been on Krystal Biotech on our site before trusting it.
Is Krystal Biotech still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 8 analysts have a real record on Krystal Biotech, the best hitting 100% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Krystal Biotech? The case for and against
The arguments for and against, one by one, from the numbers: why invest in KRYS (and why hesitate).
What has Krystal Biotech's past performance been?
Historical returns and a "how much if I had invested" calculator: KRYS performance & returns.
What is the best month to buy KRYS?
The 12 months ranked by the stock's past returns: best & worst month to buy KRYS.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX